D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VYGR holding history
Voyager Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VYGR overviewAll 13F holders of VYGRFull Q2 2026 holdings
- Shares (Q2 2026)
- 143,992
- Value
- $504.0K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 143,992 | $504.0K | <0.1% | +45,276+45.9% | Added | Holders |
| Q1 2026 | 98,716 | $381.0K | <0.1% | +98,716 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −118,828−100.0% | Sold out | Holders |
| Q3 2024 | 118,828 | $695.1K | <0.1% | −86,773−42.2% | Reduced | Holders |
| Q2 2024 | 205,601 | $1.63M | <0.1% | −28,388−12.1% | Reduced | Holders |
| Q1 2024 | 233,989 | $2.18M | <0.1% | −172,055−42.4% | Reduced | Holders |
| Q4 2023 | 406,044 | $3.43M | <0.1% | −220,079−35.1% | Reduced | Holders |
| Q3 2023 | 626,123 | $4.85M | <0.1% | −321,850−34.0% | Reduced | Holders |
| Q2 2023 | 947,973 | $10.9M | <0.1% | +319,501+50.8% | Added | Holders |
| Q1 2023 | 628,472 | $4.85M | <0.1% | −60,228−8.7% | Reduced | Holders |
| Q4 2022 | 688,700 | $4.20M | <0.1% | −16,076−2.3% | Reduced | Holders |
| Q3 2022 | 704,776 | $4.17M | <0.1% | −22,366−3.1% | Reduced | Holders |
| Q2 2022 | 727,142 | $4.30M | <0.1% | +90,921+14.3% | Added | Holders |
| Q1 2022 | 636,221 | $4.85M | <0.1% | +342,198+116.4% | Added | Holders |
| Q4 2021 | 294,023 | $797.0K | <0.1% | +294,023 | New | Holders |